204 related articles for article (PubMed ID: 36837499)
1. Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis.
Chen J; Jin H; Zhou H; Liu K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837499
[No Abstract] [Full Text] [Related]
2. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
Zhou Y; Liu Z; Cheng Y; Li J; Fu W
J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of the controlling nutritional status (CONUT) score in patients with biliary tract cancer: a meta-analysis.
Jiang H; Wang Z
Ann Med; 2023; 55(2):2261461. PubMed ID: 37751485
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis.
Chen Y; Zhang B; Liu C; Cao Y; Lyu C; Qiu M
BMJ Open; 2022 Apr; 12(4):e051421. PubMed ID: 35440445
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis.
Gong H; Chen Y; Zhou D
Pharmazie; 2020 Aug; 75(8):401-406. PubMed ID: 32758341
[No Abstract] [Full Text] [Related]
8. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
10. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract][Full Text] [Related]
11. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Jiao Y; Liu D; Sun Y; Chen Z; Liu S
Front Pharmacol; 2022; 13():850750. PubMed ID: 35645803
[No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.
Ghidini M; Tomasello G; Botticelli A; Barni S; Zabbialini G; Seghezzi S; Passalacqua R; Braconi C; Petrelli F
HPB (Oxford); 2017 Sep; 19(9):741-748. PubMed ID: 28684194
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Prognostic Nutritional Index (PNI) as a Prognostic Factor in Patients with Biliary Tract Cancer: A Meta-Analysis.
Lv X; Zhang Z; Yuan W
Nutr Cancer; 2021; 73(10):1872-1881. PubMed ID: 32933337
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
15. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies.
Yang J; Yang H; Cao L; Yin Y; Shen Y; Zhu W
Medicine (Baltimore); 2022 Dec; 101(49):e31799. PubMed ID: 36626437
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis.
Chu D; Wu J; Wang K; Zhao M; Wang C; Li L; Guo R
BMC Cancer; 2018 Apr; 18(1):438. PubMed ID: 29669520
[TBL] [Abstract][Full Text] [Related]
18. The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.
Xiao Y; Zheng L; Mei Z; Xu C; Liu C; Chu X; Hao B
Oncotarget; 2017 Nov; 8(59):100449-100458. PubMed ID: 29245991
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
20. Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.
Zhou LH; Luo XF
Clin Chim Acta; 2017 Nov; 474():102-107. PubMed ID: 28903023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
